Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bernhard

Showing results (71-80 of 155) with videos related to

Pageof 16
Sort By:
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 3, 2020
Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease BurdenAlžbeta Mühlbäck, Wiebke Frank, Olga Klempířová, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 24, 2004
Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's diseaseBirgit Zucker, Dagmar E Ludin, Thomas A Gerds, et al.
Experimental Neurology|July 6, 2011
Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's diseaseRobert Christian Wolf, Fabio Sambataro, Nenad Vasic, et al.
Plos Currents|March 30, 2012
Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's diseaseHans-Peter Müller, Sigurd D Süssmuth, G Bernhard Landwehrmeyer, et al.
Molecular Neurodegeneration|January 10, 2009
The gene coding for PGC-1alpha modifies age at onset in Huntington's DiseasePatrick Weydt, Selma M Soyal, Cinzia Gellera, et al.
Neurobiology of Disease|August 14, 2021
HAP40 protein levels are huntingtin-dependent and decrease in Huntington diseaseBin Huang, Manuel Seefelder, Eva Buck, et al.
Neuroreport|April 13, 2004
Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI studyJan Kassubek, G Bernhard Landwehrmeyer, Daniel Ecker, et al.
Journal of Contaminant Hydrology|September 19, 2002
Humic colloid-borne migration of uranium in sand columnsR Artinger, T Rabung, J I Kim, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 28, 2013
Longitudinal task-negative network analyses in preclinical Huntington's diseaseRobert Christian Wolf, Fabio Sambataro, Nenad Vasic, et al.
Medical Physics|May 6, 2004
Improving binding potential analysis in [11C]raclopride PET studies using cluster analysisGerhard Glatting, Felix M Mottaghy, Jochen Karitzky, et al.
Pageof 16

Showing results (71-80 of 155) with videos related to

Sort By:
Pageof 16
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|July 3, 2020
Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease BurdenAlžbeta Mühlbäck, Wiebke Frank, Olga Klempířová, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 24, 2004
Gabapentin-lactam, but not gabapentin, reduces protein aggregates and improves motor performance in a transgenic mouse model of Huntington's diseaseBirgit Zucker, Dagmar E Ludin, Thomas A Gerds, et al.
Experimental Neurology|July 6, 2011
Longitudinal functional magnetic resonance imaging of cognition in preclinical Huntington's diseaseRobert Christian Wolf, Fabio Sambataro, Nenad Vasic, et al.
Plos Currents|March 30, 2012
Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's diseaseHans-Peter Müller, Sigurd D Süssmuth, G Bernhard Landwehrmeyer, et al.
Molecular Neurodegeneration|January 10, 2009
The gene coding for PGC-1alpha modifies age at onset in Huntington's DiseasePatrick Weydt, Selma M Soyal, Cinzia Gellera, et al.
Neurobiology of Disease|August 14, 2021
HAP40 protein levels are huntingtin-dependent and decrease in Huntington diseaseBin Huang, Manuel Seefelder, Eva Buck, et al.
Neuroreport|April 13, 2004
Global cerebral atrophy in early stages of Huntington's disease: quantitative MRI studyJan Kassubek, G Bernhard Landwehrmeyer, Daniel Ecker, et al.
Journal of Contaminant Hydrology|September 19, 2002
Humic colloid-borne migration of uranium in sand columnsR Artinger, T Rabung, J I Kim, et al.
European Archives of Psychiatry and Clinical Neuroscience|September 28, 2013
Longitudinal task-negative network analyses in preclinical Huntington's diseaseRobert Christian Wolf, Fabio Sambataro, Nenad Vasic, et al.
Medical Physics|May 6, 2004
Improving binding potential analysis in [11C]raclopride PET studies using cluster analysisGerhard Glatting, Felix M Mottaghy, Jochen Karitzky, et al.
Pageof 16